Skip to main content

Advertisement

Log in

Multimodal biochemical modulation of 5-fluorouracil by leucovorin, methotrexate, and interferon alpha in patients with advanced colorectal cancer

  • CLINICAL TRIAL REPORT
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

 A total of 26 patients with advanced colorectal cancer received 60 mg/m2 methotrexate i. v. on days 1 – 4; 400 mg/m2 5-fluorouracil i. v. on days 2, 3, 5, and 6; and 100 mg/m2 6S-leucovorin i. v. on days 2, 3, 5, and 6. Interferon-α2b at a dose of 3 million U was given i. m. daily for the 6 days of chemotherapy. Courses were repeated every 3 weeks. There were four partial responses for a response rate of 15% (95% confidence interval 2 – 28%). In all, 14 patients expressed grade 3 toxicity; 9 patients had diarrhea, 3 had stomatitis, and 2 developed leukopenia. In conclusion, multimodal biochemical modulation of 5-fluorouracil, at least on this schedule, does not seem to be effective, as it results in severe toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 5 November 1995 / Accepted: 17 January 1996

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cascinu, S., Alessandroni, P., Rossi, D. et al. Multimodal biochemical modulation of 5-fluorouracil by leucovorin, methotrexate, and interferon alpha in patients with advanced colorectal cancer. Cancer Chemother Pharmacol 38, 385–386 (1996). https://doi.org/10.1007/s002800050499

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002800050499

Navigation